SCHEMBL29922008

SCHEMBL29922008

Cc1cc(F)c(NC(=O)C2CCC(F)(F)C2)cc1-n1cc(-c2cnc3c(N)ncnn23)cn1

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 19/20 0.40
▸ ABL1 P00519 1/20 0.36
▸ BCR P11274 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29071273 1.00 RIPK1 (0.40) RIPK1ABL1BCR
SCHEMBL29071296 0.83 ABL1 (0.33) RIPK1ABL1BCR
SCHEMBL29921409 0.83 PARP1 (0.37) RIPK1ABL1BCR
SCHEMBL29921587 0.82 ABL1 (0.33) RIPK1ABL1BCR
SCHEMBL29071280 0.78 RAF1 (0.36) RIPK1ABL1BCR
SCHEMBL29921315 0.77 RAF1 (0.39) —
SCHEMBL29071497 0.77 ABL1 (0.42) RIPK1ABL1BCR
SCHEMBL29921498 0.77 ABL1 (0.42) RIPK1ABL1BCR
SCHEMBL29071266 0.76 ABL1 (0.46) RIPK1ABL1BCR
SCHEMBL29921947 0.76 ABL1 (0.46) RIPK1ABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116761801-A Heterocyclic compounds having protein kinase inhibitory activity, pharmaceutical compositions containing the same, and methods of preparing and using the same 四川科伦博泰生物医药股份有限公司 2023-09-15 — — CN disclosed
WO-2022188792-A1 HETEROCYCLIC COMPOUND HAVING PROTEIN KINASE INHIBITORY ACTIVITY, PHARMACEUTICAL COMPOSITION COMPRISING SAME, PREPARATION METHOD THEREFOR, AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-09-15 — — WO disclosed
Send feedback